https://tepnelpharmaservices.com/mra-comes-into-force-between-the-fda-and-the-eu/ 2020-02-18T13:40:21+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2019/02/EU_UK_WEB_01.jpg https://tepnelpharmaservices.com/tepnel-pharma-services-introduces-accelerated-stability-assessment-programme-asap-to-its-stability-testing-portfolio/ 2020-03-05T18:34:00+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2019/02/Tepnel_services_introduces-e1583433036640.jpg https://tepnelpharmaservices.com/tepnel-pharma-services-have-invested-in-fusion-qbd-software/ 2020-03-30T15:16:49+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2019/02/Fusion_QbD_software-1-e1583433307155.jpg https://tepnelpharmaservices.com/asset-transfer-from-hologic/ 2020-03-30T17:24:57+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2019/01/tepnel-eye_v5.jpg https://tepnelpharmaservices.com/wp-content/uploads/2020/03/dave-scott-signature.png https://tepnelpharmaservices.com/remote-auditing-for-gmp-compliance/ 2020-04-16T16:12:05+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2019/01/tepnel-eye_v5.jpg https://tepnelpharmaservices.com/addressing-medicine-supply-chain-shortages-due-to-the-covid-19-pandemic/ 2020-04-24T13:42:06+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2019/01/tepnel-eye_v5.jpg https://tepnelpharmaservices.com/inhaled-cannabinoid-development/ 2020-11-17T11:35:09+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2020/06/inhaled-cannabinoid-development.jpg https://tepnelpharmaservices.com/anvisa-forced-degradation/ 2020-11-17T11:38:13+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2020/08/forced-degradation.jpg https://tepnelpharmaservices.com/closed-container-integrity-testing/ 2020-11-17T14:05:10+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2020/07/ccit2.jpg https://tepnelpharmaservices.com/acquity-uplc-method-development/ 2020-12-10T10:27:04+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2020/12/Enhanced-Approach-to-Method-Development.jpg https://tepnelpharmaservices.com/wp-content/uploads/2020/12/7255-Tepnel-Article-set-as-PDF_v2.jpg https://tepnelpharmaservices.com/brexit/ 2021-02-04T09:06:34+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2021/01/tepnel-lab.jpg https://tepnelpharmaservices.com/usp-small-volume-sub-visible-particle-testing/ 2021-04-01T12:08:48+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2020/11/USP-787-Small-Volume-Sub-visible-Particle-Testing-scaled.jpg https://tepnelpharmaservices.com/microbial-examinations-of-non-sterile-products/ 2021-06-03T08:44:02+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2021/05/tepnel-microbial-contamination-2.jpg https://tepnelpharmaservices.com/wp-content/uploads/2021/05/7255_Tepnel-White-Papers-Absense-of-Paper_v1.jpg https://tepnelpharmaservices.com/method-development-for-peptide-drug-products/ 2021-11-12T12:53:34+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2021/11/Method-Development-for-Peptide-Drug-Products-2.jpg https://tepnelpharmaservices.com/thinking-about-a-new-career-opportunity/ 2022-01-04T00:09:33+00:00 https://tepnelpharmaservices.com/wp-content/uploads/2020/07/New-roles.jpg